Related Experiment Video
Updated: Aug 24, 2026

LINE-1 Methylation Analysis in Mesenchymal Stem Cells Treated with Osteosarcoma-Derived Extracellular Vesicles
Published on: February 1, 2020
L1 and HERV-W retrotransposons are hypomethylated in human ovarian carcinomas
Laura Menendez1, Benedict B Benigno, John F McDonald
1Department of Genetics, University of Georgia, Life Science Building, Athens, GA 30602, USA. lmenen@uga.edu
Abstract:
Wide-spread hypomethylation of CpG dinucleotides is characteristic of many cancers. Retrotransposons have been identified as potential targets of hypomethylation during cellular transformation. We report the results of an preliminary examination of the methylation status of CpG dinucleotides associated with the L1 and HERV-W retrotransposons in benign and malignant human ovarian tumors. We find a reduction in the methylation of CpG dinucleotides within the promoter regions of these retroelements in malignant relative to non-malignant ovarian tissues. Consistent with these results, we find that relative L1 and HERV-W expression levels are elevated in representative samples of malignant vs. non-malignant ovarian tissues.
Insights
Hypomethylation of CpG sites in L1 and HERV-W retrotransposons is linked to ovarian cancer. Reduced methylation in malignant tissues correlates with increased retrotransposon expression, suggesting a role in cancer development.
Area of Science:
- Molecular Biology
- Genetics
- Oncology
Background:
- Global hypomethylation of CpG dinucleotides is a hallmark of numerous cancers.
- Retrotransposons, such as LINE-1 (L1) and Human Endogenous Retrovirus-W (HERV-W), are implicated as targets of hypomethylation during cancer development.
Purpose of the Study:
- To investigate the methylation status of CpG dinucleotides in the promoter regions of L1 and HERV-W retrotransposons.
- To examine the correlation between retrotransposon methylation and their expression levels in benign versus malignant human ovarian tumors.
Main Methods:
- Analysis of CpG dinucleotide methylation patterns in L1 and HERV-W promoter regions from human ovarian tumor tissues.
- Quantitative assessment of L1 and HERV-W expression levels in matched tumor samples.
Main Results:
- A significant reduction in CpG methylation was observed in the promoter regions of L1 and HERV-W in malignant ovarian tissues compared to benign tissues.
- Relative expression levels of L1 and HERV-W were found to be elevated in malignant ovarian samples relative to non-malignant samples.
Conclusions:
- The findings suggest that hypomethylation of L1 and HERV-W retrotransposons is associated with ovarian cancer.
- The observed hypomethylation and subsequent increased expression of these retroelements may contribute to the pathogenesis of ovarian cancer.
Related Concept Videos
Non-LTR Retrotransposons
LTR Retrotransposons
The internal coding region of LTR retrotransposons and their mechanism of transposition closely resembles a...
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
lncRNA - Long Non-coding RNAs
Mechanisms of Retrovirus-induced Cancers
Mechanisms of Retrovirus-induced Cancers

